================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(G) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
COMMISSION FILE NUMBER: 0-16664
GENETIC LABORATORIES WOUND CARE, INC.
(Exact name of Registrant as specified in its charter)
2726 Patton Road
St. Paul, MN 55113-1136
(612) 633-0805
(Address, including zip code, and
telephone number, including area code, of
Registrant's principal executive offices)
$0.01 par value common stock
(Title of each class of securities covered by this Form)
None
(Title of all other classes of securities for
which a duty to file reports under
Section 13(a) or 15(d) remains)
Please place an x in the box(es) to designate the appropriate rule provision(s)
relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [x] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 15d-6 [ ]
Rule 12h-3(b)(1)(i) [ ]
Approximate number of holders of record as of the certification or
notice date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934, Genetic
Laboratories Wound Care, Inc. has caused this certification/notice to be signed
on its behalf by the undersigned duly authorized person.
Date: September 17, 1998
GENETIC LABORATORIES WOUND CARE, INC.
By: /s/ Arthur A. Beisang
----------------------------------
Arthur A. Beisang
Chairman and Chief Executive Officer
